Cargando…
Solid Lipid Nanoparticles for Efficient Oral Delivery of Tyrosine Kinase Inhibitors: A Nano Targeted Cancer Drug Delivery
Tyrosine kinase inhibitors (TKIs) are used as targeted therapy for cancer by inhibiting the signaling pathway and tumor growth. Many TKIs got approved by FDA in recent times for the treatment of cancer by oral route. However, the TKIs have formulation challenges leading to compromised bioavailabilit...
Autores principales: | Satapathy, Sukanta, Patro, Chandra Sekhar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tabriz University of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106966/ https://www.ncbi.nlm.nih.gov/pubmed/35620346 http://dx.doi.org/10.34172/apb.2022.041 |
Ejemplares similares
-
Solid Lipid Nanoparticles: Emerging Colloidal Nano Drug Delivery Systems
por: Mishra, Vijay, et al.
Publicado: (2018) -
Oral insulin delivery by means of solid lipid nanoparticles
por: Sarmento, Bruno, et al.
Publicado: (2007) -
Solid Lipid Nanoparticles for Duodenum Targeted Oral Delivery of Tilmicosin
por: Zhou, Kaixiang, et al.
Publicado: (2020) -
Multi-target tyrosine kinase inhibitor nanoparticle delivery systems for cancer therapy
por: Xu, Wenjing, et al.
Publicado: (2022) -
Insights into Lipid-Based Delivery Nanosystems of Protein-Tyrosine Kinase Inhibitors for Cancer Therapy
por: Jampilek, Josef, et al.
Publicado: (2022)